Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated (ELAN)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
21. 28
+0.01
+0.05%
$
11.58B Market Cap
- P/E Ratio
0% Div Yield
4,330,209 Volume
- Eps
$ 21.27
Previous Close
Day Range
20.96 21.49
Year Range
8.02 23.7
Want to track ELAN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days

Summary

ELAN closed yesterday higher at $21.28, an increase of 0.05% from Thursday's close, completing a monthly decrease of -6.01% or $1.36. Over the past 12 months, ELAN stock gained 74.14%.
ELAN is not paying dividends to its shareholders.
The last earnings report, released on Nov 11, 2025, missed the consensus estimates by -0.13%. On average, the company has fell short of earnings expectations by -0.09%, based on the last three reports. The next scheduled earnings report is due on Feb 24, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ELAN Chart

Similar

APH
Amphenol Corporation
$ 129.23
-7.09%
TJX
Tjx Companies Inc.
$ 156.06
+0.31%
LOW
Lowe's Companies Inc.
$ 247.29
-0.32%
NKE
Nike Inc.
$ 67.49
-0.37%
SHW
The Sherwin-Williams Company
$ 328.48
-0.25%
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy

All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy

Elanco Animal Health (ELAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 days ago
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript

Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript

Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript

Seekingalpha | 2 days ago
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Seekingalpha | 1 week ago

Elanco Animal Health Incorporated (ELAN) FAQ

What is the stock price today?

The current price is $21.28.

On which exchange is it traded?

Elanco Animal Health Incorporated is listed on NYSE.

What is its stock symbol?

The ticker symbol is ELAN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 11.58B.

What is the earnings per share?

The EPS is 0.11.

When is the next earnings date?

The next earnings report will release on Feb 24, 2026.

Has Elanco Animal Health Incorporated ever had a stock split?

No, there has never been a stock split.

Elanco Animal Health Incorporated Profile

Specialty Retail Industry
Consumer Discretionary Sector
Jeffrey N. Simmons CEO
NYSE Exchange
28414H103 CUSIP
US Country
9,000 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Elanco Animal Health Incorporated is an animal health company founded in 1954 with its headquarters in Greenfield, Indiana. Specializing in the innovation, development, manufacturing, and marketing of products for pets and farm animals, Elanco aims to improve the health and productivity of those animals through a comprehensive range of products. The company distributes its offerings globally, catering to third-party distributors, veterinarians, and farm animal producers, which include beef and dairy farmers, as well as those involved in pork, poultry, and aquaculture operations.

Products and Services

  • Pet Health Disease Prevention: Elanco provides a variety of parasiticide and vaccine products under brands such as Seresto, Advantage, Advantix, and Advocate. These products are designed to protect pets from common pests like worms, fleas, and ticks.
  • Pet Health Therapeutics: The company offers products for pain, osteoarthritis, ear infections, cardiovascular issues, and dermatology symptoms in dogs and cats. Notable brands include Galliprant and Claro, which serve to enhance the well-being of pets and treat common health conditions.
  • Poultry and Aquaculture Production: For the poultry and aquaculture sectors, Elanco markets vaccines, antibiotics, parasiticides, and other essential products. They also provide nutritional health products such as enzymes, probiotics, and prebiotics to support the overall health and productivity of animals in these industries.
  • Ruminant and Swine Production: Elanco supports ruminant and swine producers with a vast array of products including vaccines, antibiotics, implants, and parasiticides. Noteworthy brands such as Rumensin and Baytril play a significant role in ensuring the health and efficiency of these farm animals. These products are integral in enhancing feed efficiency, preventing disease, and maintaining the health of livestock.

Contact Information

Address: 2500 Innovation Way
Phone: 877 352 6261